Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
about
Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice.Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.
P2860
Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Acid Ceramidase Deficiency is ...... le that is altered by therapy.
@en
type
label
Acid Ceramidase Deficiency is ...... le that is altered by therapy.
@en
prefLabel
Acid Ceramidase Deficiency is ...... le that is altered by therapy.
@en
P2093
P50
P1476
Acid Ceramidase Deficiency is ...... ile that is altered by therapy
@en
P2093
Alexander Solyom
Andrea Jarisch
Aneal Khan
Balahan Makay
Bo Magnusson
Boris Hugle
Bruno Maranda
Charles Marques Lorenco
Edward H Schuchman
James S Norris
P304
P356
10.1016/J.BBADIS.2016.11.031
P577
2016-12-01T00:00:00Z